Compare TORM plc (TRMD) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TORM plc vs Zoetis Inc — how do they compare? TORM plc trades at $39.94 (market cap $4.12B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 7.3× TORM plc's market cap, and TORM plc pays the higher dividend (11.03%). Which is the better fit depends on your goals — on Pluang, investors hold TORM plc for 23 Days and Zoetis Inc for 70 Days on average.
| TRMD | ZTS | |
|---|---|---|
Market Cap | $4.12B | $30.20B |
Volume | 2,863,116 | 6,175,327 |
Sector | Industrials | Health |
52-Week High | $41.05 | $147.53 |
52-Week Low | $19.39 | $69.09 |
Typical Hold Time | 23 Days | 70 Days |
Enterprise Value | $4.83B | $37.76B |
Dividend Yield | 11.03% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TRMD trades at $39.94, up 2.62% today, with a bullish technical signal from moving averages. The stock shows strong profitability with a 35.52% net income margin and a low P/E of 6.59, indicating potential undervaluation. Recent earnings saw a mix of beats and misses, with Q3 2026 results pending. A $2.40 dividend is scheduled for payment in September 2026, and cash flow trends improved to a net positive in 2026.
The outlook is supported by robust fundamentals and a unanimous buy rating from analysts, but risks include volatile spot rates in the tanker market and recent insider selling. Revenue growth to $1.8B in 2026 underscores operational strength, yet dependence on freight rates poses a near-term headwind for sustained gains.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
